Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical trial of Tocilizumab for adult onset still disease

Trial Profile

Clinical trial of Tocilizumab for adult onset still disease

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Oct 2018

At a glance

  • Drugs Tocilizumab (Primary) ; Tocilizumab (Primary)
  • Indications Adult-onset Still's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2018 New trial record
    • 02 Oct 2018 Primary endpoint has not been met. (Part 2: Proportion of Patients who achieved ACR 50% improvement at 12 weeks)
    • 02 Oct 2018 Primary endpoint has not been met. (Part 1:Proportion of Patients who achieved ACR 50% improvement at 4 weeks.)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top